NASDAQ:NEPT Neptune Wellness Solutions Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Neptune Wellness Solutions Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.50 +0.01 (+0.40 %) (As of 09/18/2020 09:33 PM ET) Add Compare Share Today's Range$2.43Now: $2.50▼$2.5550-Day Range$2.31MA: $2.70▼$3.0752-Week Range$0.96Now: $2.50▼$4.09Volume441,200 shsAverage Volume991,490 shsMarket Capitalization$280.37 millionP/E RatioN/ADividend YieldN/ABeta2.62 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Neptune Wellness Solutions Inc., a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada. Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingNeptune Wellness Solutions has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.88, Neptune Wellness Solutions has a forecasted upside of 95.0% from its current price of $2.50.Amount of Analyst CoverageNeptune Wellness Solutions has only been the subject of 1 research reports in the past 90 days. Previous Next 2.6 Community Rank Outperform VotesNeptune Wellness Solutions has received 148 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNeptune Wellness Solutions has received 142 “underperform” votes. (Add your “underperform” vote.)Community SentimentNeptune Wellness Solutions has received 51.03% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Neptune Wellness Solutions and other stocks. Vote “Outperform” if you believe NEPT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NEPT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldNeptune Wellness Solutions does not currently pay a dividend.Dividend GrowthNeptune Wellness Solutions does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Neptune Wellness Solutions insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 18.04% of the stock of Neptune Wellness Solutions is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Neptune Wellness Solutions are expected to grow in the coming year, from ($0.19) to $0.05 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Neptune Wellness Solutions is -4.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Neptune Wellness Solutions is -4.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNeptune Wellness Solutions has a P/B Ratio of 2.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.3Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.31 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NEPT Previous Symbol CUSIPN/A CIK1401395 Webwww.neptunecorp.com Phone45-0687-2262Debt Debt-to-Equity Ratio0.01 Current Ratio2.56 Quick Ratio2.08Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$22.05 million Price / Sales12.71 Cash FlowN/A Price / Cash FlowN/A Book Value$1.09 per share Price / Book2.29Profitability EPS (Most Recent Fiscal Year)($0.43) Net Income$-45,760,000.00 Net Margins-142.42% Return on Equity-47.06% Return on Assets-33.97%Miscellaneous Employees58 Outstanding Shares112,146,000Market Cap$280.37 million Next Earnings Date11/9/2020 (Estimated) OptionableOptionable $2.50 +0.01 (+0.40 %) (As of 09/18/2020 09:33 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive NEPT News and Ratings via Email Sign-up to receive the latest news and ratings for NEPT and its competitors with MarketBeat's FREE daily newsletter. Neptune Wellness Solutions (NASDAQ:NEPT) Frequently Asked Questions How has Neptune Wellness Solutions' stock been impacted by Coronavirus (COVID-19)? Neptune Wellness Solutions' stock was trading at $1.21 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NEPT stock has increased by 106.6% and is now trading at $2.50. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Neptune Wellness Solutions? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Neptune Wellness Solutions. When is Neptune Wellness Solutions' next earnings date? Neptune Wellness Solutions is scheduled to release its next quarterly earnings announcement on Monday, November 9th 2020. View our earnings forecast for Neptune Wellness Solutions. How were Neptune Wellness Solutions' earnings last quarter? Neptune Wellness Solutions Inc (NASDAQ:NEPT) released its earnings results on Tuesday, August, 11th. The biotechnology company reported ($0.09) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.05) by $0.04. The biotechnology company had revenue of $15.41 million for the quarter, compared to analyst estimates of $15.50 million. Neptune Wellness Solutions had a negative net margin of 142.42% and a negative return on equity of 47.06%. View Neptune Wellness Solutions' earnings history. What guidance has Neptune Wellness Solutions issued on next quarter's earnings? Neptune Wellness Solutions issued an update on its second quarter 2021 After-Hours earnings guidance on Tuesday, August, 11th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $28-32 million. What price target have analysts set for NEPT? 3 analysts have issued 12-month target prices for Neptune Wellness Solutions' stock. Their forecasts range from $3.75 to $6.00. On average, they anticipate Neptune Wellness Solutions' share price to reach $4.88 in the next year. This suggests a possible upside of 95.0% from the stock's current price. View analysts' price targets for Neptune Wellness Solutions. Who are some of Neptune Wellness Solutions' key competitors? Some companies that are related to Neptune Wellness Solutions include BioXcel Therapeutics (BTAI), Esperion Therapeutics (ESPR), Athenex (ATNX), Gossamer Bio (GOSS), Constellation Pharmaceuticals (CNST), Retrophin (RTRX), I-Mab (ARQT), Legend Biotech (PLRX), Enanta Pharmaceuticals (ENTA), Amphastar Pharmaceuticals (AMPH), RAPT Therapeutics (RAPT), Passage Bio (KROS), Akouos (AKUS), Vectura Group (VEGPF) and Provention Bio (PRVB). View all competitors. What other stocks do shareholders of Neptune Wellness Solutions own? Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include Canopy Growth (CGC), Tilray (TLRY), Aurora Cannabis (ACB), Cronos Group (CRON), Aphria (APHA), Innovative Industrial Properties (IIPR), Cara Therapeutics (CARA), Zynerba Pharmaceuticals (ZYNE), Amarin (AMRN) and OrganiGram (OGI). Who are Neptune Wellness Solutions' key executives? Neptune Wellness Solutions' management team includes the following people: Mr. James S. Hamilton, Pres, CEO & DirectorMr. Mario Paradis, VP & CFOMr. Marc Vaugeois, VP of SalesMr. Michel Timperio, Pres of Cannabis Bus.Mr. François-Karl Brouillette, VP of Science & Innovation of Nutraceutical Bus. What is Neptune Wellness Solutions' stock symbol? Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT." Who are Neptune Wellness Solutions' major shareholders? Neptune Wellness Solutions' stock is owned by a number of institutional and retail investors. Top institutional investors include Perceptive Advisors LLC (16.52%), AdvisorShares Investments LLC (0.40%), Commonwealth Equity Services LLC (0.14%), Bank of America Corp DE (0.07%), Bank of Montreal Can (0.07%) and Hilton Capital Management LLC (0.07%). Which institutional investors are selling Neptune Wellness Solutions stock? NEPT stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can. Which institutional investors are buying Neptune Wellness Solutions stock? NEPT stock was acquired by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Hilton Capital Management LLC, Commonwealth Equity Services LLC, Bank of America Corp DE, Goldman Sachs Group Inc., AdvisorShares Investments LLC, and Cambria Investment Management L.P.. How do I buy shares of Neptune Wellness Solutions? Shares of NEPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Neptune Wellness Solutions' stock price today? One share of NEPT stock can currently be purchased for approximately $2.50. How big of a company is Neptune Wellness Solutions? Neptune Wellness Solutions has a market capitalization of $280.37 million and generates $22.05 million in revenue each year. The biotechnology company earns $-45,760,000.00 in net income (profit) each year or ($0.43) on an earnings per share basis. Neptune Wellness Solutions employs 58 workers across the globe. What is Neptune Wellness Solutions' official website? The official website for Neptune Wellness Solutions is www.neptunecorp.com. How can I contact Neptune Wellness Solutions? Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262 or via email at [email protected] This page was last updated on 9/21/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
